Formulation Development Outsourcing Market Report 2026

Formulation Development Outsourcing Market Overview

• Formulation Development Outsourcing market size has reached to $32.32 billion in 2025 • Expected to grow to $53.3 billion in 2030 at a compound annual growth rate (CAGR) of 10.7% • Growth Driver: Surging Drugs Demand Is Anticipated To Fuel The Formulation Development Outsourcing Market Growth • Market Trend: Technology Trends Reshaping Formulation Development Outsourcing Market • North America was the largest region in 2025.

What Is Covered Under Formulation Development Outsourcing Market?

Formulation development outsourcing refers to the practice of hiring external experts or organizations to handle the process of formulating and developing a product. This outsourcing arrangement allows companies to leverage the specialized knowledge, resources, and expertise of external parties to develop or improve the formulation of their products. The main services of formulation development outsourcing are pre-formulation, and formulation development. Preformulation refers to the stage of development in pharmaceutical formulations. The various therapeutic area includes oncology, infectious disease, neurology, hematology, respiratory, cardiovascular, dermatology, others, for various formulations include oral, injectable, topical, other formulations. It is used by various end-user including pharmaceutical industries, research, and academic development.

What Is The Formulation Development Outsourcing Market Growth Forecast?

The formulation development outsourcing market size is expected to see rapid growth in the next few years. It will grow to $53.3 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing demand for biologics and complex formulations, rising outsourcing by emerging pharma companies, expansion of personalized medicine development, growing adoption of advanced formulation technologies, increasing focus on accelerated time-to-market. Major trends in the forecast period include increasing outsourcing of complex drug formulations, rising adoption of quality by design approaches, growing demand for injectable and specialized dosage forms, expansion of scale-up and technology transfer services, enhanced focus on regulatory-compliant formulation development.

What Is The Driver Of The Formulation Development Outsourcing Market?

Growing demand for drugs is expected to propel the growth of the formulation development outsourcing market going forward. Drug refers to substances that can be used for various purposes, including medical treatment, prevention of diseases, relief of symptoms, or recreation. Formulation development outsourcing plays a crucial role in drug development such as supporting the development of biopharmaceuticals and novel drug delivery systems, accelerating the drug development process, providing a cost-effective solution for pharma companies, and others. For instance, in April 2025, according to Eurostat, a Luxembourg-based government agency, in 2024, EU exports of medicinal and pharmaceutical products increased by 13.5% compared with 2023, reaching $316.38 billion (€313.4 billion). At the same time, imports only recorded a modest increase of 0.5%, amounting to $112.7 billion (€119.7 billion). Therefore, the growing demand for drugs is driving the growth of the formulation development outsourcing industry.

Key Players In The Global Formulation Development Outsourcing Market

Major companies operating in the formulation development outsourcing market include Syngene International Ltd., Aizant Drug Research Solutions Private Limited., Catalent Inc., Intertek Group plc, Recipharm AB, SGS S.A., Lonza Group AG, Eurofins Scientific SE, Laboratory Corporation of America Holdings, Charles River Laboratories International Inc., Emergent Biosolutions Inc., IRISYS LLC, Piramal Pharma Limited., Biocon Limited., Dr Reddy's Laboratories Ltd., Quotient Sciences Ltd., Almac Group, Patheon, Evonik Industries AG, Metrics Contract Services, Aenova Group, Fareva Group, Vetter Pharma International GmbH, Aesica Pharmaceuticals, WuXi AppTec, Formosa Laboratories Inc., Aptuit LLC, ProPharma Group, Laurus Labs Limited

Global Formulation Development Outsourcing Market Trends and Insights

Major companies operating in the formulation development outsourcing market are focusing on developing innovative solutions, such as AI powered generative cloud platforms, to meet the rising demand for accelerated drug discovery, optimized molecular design, and more efficient R&D workflows. Generative AI cloud platforms leverage pre trained machine learning models and high performance computing to automate and enhance complex tasks in drug formulation and discovery, offering significant improvements over traditional computational chemistry and manual screening methods by enabling rapid protein structure prediction, molecule generation, and data driven optimization at scale. For instance, in March 2023, NVIDIA, a US based software technology company, launched BioNeMo Cloud, a generative AI service within its AI Foundations suite designed to accelerate life sciences research, drug discovery, and protein engineering by providing researchers with access to customizable, pre trained AI models that can be fine tuned with proprietary data to support tasks such as target identification and molecular design directly through cloud APIs or a web browser interface. This cloud based platform includes optimized generative AI workflows for protein structure prediction, docking, and molecule generation, helping to shorten the most time consuming stages of drug development compared with conventional in house computational efforts and manual experimentation, and has been adopted by companies like Amgen and several biotech startups to drive faster, data driven innovation.

What Are Latest Mergers And Acquisitions In The Formulation Development Outsourcing Market?

In April 2024, CoreRx Inc., a US-based contract development and manufacturing organization (CDMO) company, acquired Societal CDMO Inc. for an undisclosed amount. With this acquisition, CoreRx aims to enhance its formulation development and manufacturing capacity, expand its service offerings from early-stage to commercial-scale manufacturing, and meet increasing demand from pharmaceutical clients for integrated development-to-manufacture outsourcing services. Societal CDMO Inc. is a US-based company that specializes in complex formulation development and manufacturing for small molecule drugs, offering services ranging from early-phase development to commercial production.

What Defines the Formulation Development Outsourcing Market?

The formulation development outsourcing market includes revenues earned by entities by providing services such as ingredient sourcing, stability studies, analytical testing, and regulatory support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Formulation Development Outsourcing Market Report 2026?

The formulation development outsourcing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the formulation development outsourcing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.